Mission Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.21M Buy
25,436
+16,021
+170% +$5.48M 0.11% 113
2026
Q1
$3.31M Sell
9,415
-911
-9% -$325K 0.07% 151
2025
Q4
$3.38M Sell
10,326
-263
-2% -$83.4K 0.07% 158
2025
Q3
$2.99M Sell
10,589
-781
-7% -$226K 0.06% 171
2025
Q2
$3.17M Buy
11,370
+379
+3% +$107K 0.07% 159
2025
Q1
$3.42M Buy
10,991
+528
+5% +$156K 0.08% 133
2024
Q4
$2.73M Sell
10,463
-1,896
-15% -$563K 0.06% 154
2024
Q3
$3.98M Buy
12,359
+493
+4% +$161K 0.1% 114
2024
Q2
$3.71M Sell
11,866
-795
-6% -$234K 0.1% 117
2024
Q1
$3.6M Buy
12,661
+108
+0.9% +$31.6K 0.09% 123
2023
Q4
$3.62M Buy
12,553
+1,022
+9% +$278K 0.12% 98
2023
Q3
$3.1M Sell
11,531
-394
-3% -$98.3K 0.12% 97
2023
Q2
$2.65M Sell
11,925
-148
-1% -$34.3K 0.1% 105
2023
Q1
$2.92M Buy
12,073
+297
+3% +$72.9K 0.12% 95
2022
Q4
$3.09M Buy
11,776
+146
+1% +$39.1K 0.15% 89
2022
Q3
$2.62M Sell
11,630
-936
-7% -$227K 0.14% 95
2022
Q2
$3.06M Buy
12,566
+2,156
+21% +$528K 0.16% 79
2022
Q1
$2.52M Sell
10,410
-374
-3% -$85.9K 0.12% 97
2021
Q4
$2.43M Sell
10,784
-597
-5% -$126K 0.11% 102
2021
Q3
$2.42M Buy
11,381
+749
+7% +$172K 0.12% 95
2021
Q2
$2.59M Buy
10,632
+214
+2% +$52.6K 0.14% 81
2021
Q1
$2.59M Buy
10,418
+3,499
+51% +$835K 0.15% 75
2020
Q4
$1.59M Sell
6,919
-744
-10% -$172K 0.1% 97
2020
Q3
$1.95M Buy
7,663
+768
+11% +$190K 0.15% 76
2020
Q2
$1.63M Buy
6,895
+107
+2% +$24.4K 0.14% 81
2020
Q1
$1.38M Sell
6,788
-165
-2% -$36K 0.15% 80
2019
Q4
$1.68M Buy
6,953
+272
+4% +$60K 0.16% 82
2019
Q3
$1.29M Buy
6,681
+128
+2% +$24.6K 0.14% 87
2019
Q2
$1.21M Buy
6,553
+846
+15% +$151K 0.14% 84
2019
Q1
$1.08M Sell
5,707
-2,813
-33% -$537K 0.13% 90
2018
Q4
$1.66M Sell
8,520
-149
-2% -$29.1K 0.22% 61
2018
Q3
$1.8M Buy
8,669
+176
+2% +$34.7K 0.24% 59
2018
Q2
$1.57M Buy
8,493
+207
+2% +$36.6K 0.23% 57
2018
Q1
$1.41M Sell
8,286
-77
-0.9% -$14.1K 0.23% 50
2017
Q4
$1.45M Buy
8,363
+479
+6% +$84.8K 0.25% 49
2017
Q3
$1.47M Sell
7,884
-8,260
-51% -$1.46M 0.27% 46
2017
Q2
$2.78M Sell
16,144
-62
-0.4% -$10.1K 0.53% 30
2017
Q1
$2.66M Buy
16,206
+104
+0.6% +$17.3K 0.52% 28
2016
Q4
$2.35M Buy
16,102
+30
+0.2% +$4.51K 0.47% 30
2016
Q3
$2.68M Sell
16,072
-990
-6% -$167K 0.65% 22
2016
Q2
$2.6M Sell
17,062
-73
-0.4% -$11.3K 0.69% 21
2016
Q1
$2.57M Buy
17,135
+203
+1% +$30.2K 0.69% 21
2015
Q4
$2.75M Buy
16,932
+6,627
+64% +$1.04M 0.77% 19
2015
Q3
$1.43M Sell
10,305
-6,210
-38% -$979K 0.43% 26
2015
Q2
$2.64M Buy
+16,515
New +$2.65M 0.9% 20

Other funds holding AMGN

Mission Wealth Management's AMGN Position: Q2 2026 in Review

Mission Wealth Management increased its Amgen (AMGN) stake by 170% in Q2 2026, buying an estimated $5.48M and bringing the position to 25,436 shares worth $9.21M. The position accounts for 0.11% of the portfolio, ranked #113.

Mission Wealth Management first reported a position in AMGN in Q2 2015 and has held it in 45 quarters since. 1,324 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Mission Wealth Management held 25,436 shares of Amgen worth $9.21M as of Q2 2026.
  • Mission Wealth Management bought 16,021 Amgen shares in Q2 2026, an estimated $5.48M.
  • Amgen made up 0.11% of Mission Wealth Management's portfolio in Q2 2026, its #113 holding.
  • Mission Wealth Management first reported a position in Amgen in Q2 2015 and has held it in 45 quarters since.
  • 1,324 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Mission Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.